PriceTargets.com logo

Defiance Trillion Dollar Club Index ETF - TRIL Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$20.51 As of 12/4/2025 01:00 AM ET
▲ +0.0509 (0.25%)
Get New Defiance Trillion Dollar Club Index ETF Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TRIL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TRIL

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Defiance Trillion Dollar Club Index ETF in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $20.51.

This chart shows the closing price for TRIL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Defiance Trillion Dollar Club Index ETF. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/17/2021BenchmarkDowngradeBuy ➝ Hold
10/1/2021Bloom BurtonInitiated CoverageBuy ➝ Hold$18.50
8/24/2021Craig HallumDowngradeBuy ➝ Hold$21.00 ➝ $18.50
8/24/2021JMP SecuritiesDowngradeOutperform ➝ Market Perform
8/23/2021HC WainwrightDowngradeBuy ➝ NeutralC$22.00 ➝ C$18.50
4/29/2021Bloom BurtonUpgradeAccumulate ➝ Buy
4/26/2021JonestradingReiterated RatingBuy$25.00
4/14/2021BenchmarkInitiated CoverageBuy$21.00
3/22/2021HC WainwrightReiterated RatingBuy$22.00
3/19/2021JonestradingReiterated RatingBuy$25.00
12/8/2020Bloom BurtonDowngradeBuy ➝ Accumulate
(Data available from 12/5/2020 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Defiance Trillion Dollar Club Index ETF logo
Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.
Read More

Today's Range

Now: $20.51
Low: $20.43
High: $20.51

50 Day Range

MA: $18.12
Low: $17.50
High: $18.44

52 Week Range

Now: $20.51
Low: $5.80
High: $20.96

Volume

883 shs

Average Volume

1,866,404 shs

Market Capitalization

$2.15 billion

P/E Ratio

33.08

Dividend Yield

N/A

Beta

2.08

Frequently Asked Questions

What sell-side analysts currently cover shares of Defiance Trillion Dollar Club Index ETF?

The following Wall Street research analysts have issued reports on Defiance Trillion Dollar Club Index ETF in the last twelve months:
View the latest analyst ratings for TRIL.

What is the current price target for Defiance Trillion Dollar Club Index ETF?

0 Wall Street analysts have set twelve-month price targets for Defiance Trillion Dollar Club Index ETF in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Defiance Trillion Dollar Club Index ETF in the next year.
View the latest price targets for TRIL.

What is the current consensus analyst rating for Defiance Trillion Dollar Club Index ETF?

Defiance Trillion Dollar Club Index ETF currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for TRIL.

How do I contact Defiance Trillion Dollar Club Index ETF's investor relations team?

Defiance Trillion Dollar Club Index ETF's physical mailing address is 2488 DUNWIN DRIVE, MISSISSAUGA A6, L5L 1J9. The biotechnology company's listed phone number is (416) 595-0627 and its investor relations email address is [email protected]. The official website for Defiance Trillion Dollar Club Index ETF is www.trilliumtherapeutics.com. Learn More about contacing Defiance Trillion Dollar Club Index ETF investor relations.